No, Copaxone is not classified as an immunosuppressant. Instead, it's considered an immunomodulator, meaning it modifies the immune system's response rather than suppressing it. It helps to prevent the immune system from attacking the myelin sheath in the central nervous system, which is a common issue in Multiple Sclerosis.